Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.69706031 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.69706031 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.46593460 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.46593460 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.02129077 |
6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.76930652 |
7 | glyoxylate metabolic process (GO:0046487) | 5.65720832 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.53728844 |
9 | cysteine metabolic process (GO:0006534) | 5.43178309 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.41954019 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.41954019 |
12 | tryptophan catabolic process (GO:0006569) | 5.41954019 |
13 | lysine catabolic process (GO:0006554) | 5.36860563 |
14 | lysine metabolic process (GO:0006553) | 5.36860563 |
15 | kynurenine metabolic process (GO:0070189) | 5.32081066 |
16 | sulfur amino acid catabolic process (GO:0000098) | 5.23002429 |
17 | bile acid biosynthetic process (GO:0006699) | 5.18692114 |
18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.15072355 |
19 | tryptophan metabolic process (GO:0006568) | 5.13823793 |
20 | urea cycle (GO:0000050) | 4.98255586 |
21 | urea metabolic process (GO:0019627) | 4.98255586 |
22 | homocysteine metabolic process (GO:0050667) | 4.80842262 |
23 | serine family amino acid catabolic process (GO:0009071) | 4.79983216 |
24 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.79031295 |
25 | complement activation, alternative pathway (GO:0006957) | 4.76851958 |
26 | amino-acid betaine metabolic process (GO:0006577) | 4.65413483 |
27 | negative regulation of fibrinolysis (GO:0051918) | 4.64024351 |
28 | regulation of triglyceride catabolic process (GO:0010896) | 4.62366135 |
29 | nitrogen cycle metabolic process (GO:0071941) | 4.58230319 |
30 | protein carboxylation (GO:0018214) | 4.57632984 |
31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.57632984 |
32 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.57103956 |
33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.54026979 |
34 | regulation of protein activation cascade (GO:2000257) | 4.50003244 |
35 | bile acid metabolic process (GO:0008206) | 4.46416487 |
36 | aromatic amino acid family metabolic process (GO:0009072) | 4.35986295 |
37 | regulation of fibrinolysis (GO:0051917) | 4.35338232 |
38 | alpha-amino acid catabolic process (GO:1901606) | 4.33993381 |
39 | plasma lipoprotein particle clearance (GO:0034381) | 4.30423419 |
40 | acetyl-CoA metabolic process (GO:0006084) | 4.28510812 |
41 | cellular ketone body metabolic process (GO:0046950) | 4.24960635 |
42 | regulation of complement activation (GO:0030449) | 4.24821464 |
43 | acylglycerol homeostasis (GO:0055090) | 4.22756281 |
44 | triglyceride homeostasis (GO:0070328) | 4.22756281 |
45 | triglyceride catabolic process (GO:0019433) | 4.19772435 |
46 | tyrosine metabolic process (GO:0006570) | 4.17288649 |
47 | serine family amino acid metabolic process (GO:0009069) | 4.12144959 |
48 | cellular amino acid catabolic process (GO:0009063) | 4.11266869 |
49 | regulation of cholesterol esterification (GO:0010872) | 4.11264095 |
50 | reverse cholesterol transport (GO:0043691) | 4.10943100 |
51 | fatty acid beta-oxidation (GO:0006635) | 4.10202571 |
52 | valine metabolic process (GO:0006573) | 4.05771294 |
53 | negative regulation of cholesterol transport (GO:0032375) | 4.05217633 |
54 | negative regulation of sterol transport (GO:0032372) | 4.05217633 |
55 | macromolecular complex remodeling (GO:0034367) | 4.04262977 |
56 | plasma lipoprotein particle remodeling (GO:0034369) | 4.04262977 |
57 | protein-lipid complex remodeling (GO:0034368) | 4.04262977 |
58 | short-chain fatty acid metabolic process (GO:0046459) | 4.03763833 |
59 | ethanol oxidation (GO:0006069) | 4.03737562 |
60 | cellular modified amino acid catabolic process (GO:0042219) | 4.01040656 |
61 | drug catabolic process (GO:0042737) | 3.99269442 |
62 | glycine metabolic process (GO:0006544) | 3.99177538 |
63 | urate metabolic process (GO:0046415) | 3.98076127 |
64 | fatty acid oxidation (GO:0019395) | 3.95856518 |
65 | drug transmembrane transport (GO:0006855) | 3.94244991 |
66 | 2-oxoglutarate metabolic process (GO:0006103) | 3.92829343 |
67 | serine family amino acid biosynthetic process (GO:0009070) | 3.90884257 |
68 | glutamate metabolic process (GO:0006536) | 3.90825051 |
69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.88786986 |
70 | lipid oxidation (GO:0034440) | 3.88701162 |
71 | acylglycerol catabolic process (GO:0046464) | 3.88069217 |
72 | neutral lipid catabolic process (GO:0046461) | 3.88069217 |
73 | cellular glucuronidation (GO:0052695) | 3.86491635 |
74 | aspartate family amino acid catabolic process (GO:0009068) | 3.83720426 |
75 | coenzyme catabolic process (GO:0009109) | 3.82933928 |
76 | indolalkylamine metabolic process (GO:0006586) | 3.79150386 |
77 | phospholipid efflux (GO:0033700) | 3.79105610 |
78 | fatty acid catabolic process (GO:0009062) | 3.78882710 |
79 | regulation of cholesterol homeostasis (GO:2000188) | 3.78294663 |
80 | benzene-containing compound metabolic process (GO:0042537) | 3.77591370 |
81 | organic acid catabolic process (GO:0016054) | 3.76552309 |
82 | carboxylic acid catabolic process (GO:0046395) | 3.76552309 |
83 | positive regulation of lipid catabolic process (GO:0050996) | 3.74615517 |
84 | regulation of plasminogen activation (GO:0010755) | 3.72661123 |
85 | monocarboxylic acid catabolic process (GO:0072329) | 3.72563504 |
86 | cell adhesion mediated by integrin (GO:0033627) | 3.68291440 |
87 | amine catabolic process (GO:0009310) | 3.67956582 |
88 | cellular biogenic amine catabolic process (GO:0042402) | 3.67956582 |
89 | carnitine metabolic process (GO:0009437) | 3.67496957 |
90 | ketone body metabolic process (GO:1902224) | 3.67169171 |
91 | phospholipid homeostasis (GO:0055091) | 3.66939510 |
92 | bile acid and bile salt transport (GO:0015721) | 3.66825483 |
93 | fatty acid homeostasis (GO:0055089) | 3.63202019 |
94 | fibrinolysis (GO:0042730) | 3.63179957 |
95 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60476613 |
96 | branched-chain amino acid catabolic process (GO:0009083) | 3.59338210 |
97 | aldehyde catabolic process (GO:0046185) | 3.58986302 |
98 | cholesterol homeostasis (GO:0042632) | 3.55350181 |
99 | NADH metabolic process (GO:0006734) | 3.53908269 |
100 | cholesterol efflux (GO:0033344) | 3.53106920 |
101 | sterol homeostasis (GO:0055092) | 3.51973451 |
102 | plasma lipoprotein particle assembly (GO:0034377) | 3.51617513 |
103 | glucuronate metabolic process (GO:0019585) | 3.51092110 |
104 | uronic acid metabolic process (GO:0006063) | 3.51092110 |
105 | branched-chain amino acid metabolic process (GO:0009081) | 3.50876583 |
106 | apoptotic cell clearance (GO:0043277) | 3.49677420 |
107 | regulation of sequestering of triglyceride (GO:0010889) | 3.48595588 |
108 | low-density lipoprotein particle clearance (GO:0034383) | 3.47122893 |
109 | biotin metabolic process (GO:0006768) | 3.46755150 |
110 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46246817 |
111 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46246817 |
112 | protein heterotrimerization (GO:0070208) | 3.45499223 |
113 | imidazole-containing compound metabolic process (GO:0052803) | 3.44186657 |
114 | endodermal cell differentiation (GO:0035987) | 3.39842585 |
115 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.39468521 |
116 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.19509707 |
117 | COPI coating of Golgi vesicle (GO:0048205) | 3.16309228 |
118 | Golgi transport vesicle coating (GO:0048200) | 3.16309228 |
119 | polyketide metabolic process (GO:0030638) | 3.15074812 |
120 | doxorubicin metabolic process (GO:0044598) | 3.15074812 |
121 | daunorubicin metabolic process (GO:0044597) | 3.15074812 |
122 | barbed-end actin filament capping (GO:0051016) | 3.13083485 |
123 | epoxygenase P450 pathway (GO:0019373) | 3.03003019 |
124 | basement membrane organization (GO:0071711) | 3.02694512 |
125 | omega-hydroxylase P450 pathway (GO:0097267) | 3.00653473 |
126 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.00012452 |
127 | skin morphogenesis (GO:0043589) | 2.97532465 |
128 | oxaloacetate metabolic process (GO:0006107) | 2.92562861 |
129 | negative regulation of fatty acid transport (GO:2000192) | 2.86821445 |
130 | endothelial cell morphogenesis (GO:0001886) | 2.84457273 |
131 | negative regulation of lipase activity (GO:0060192) | 2.82265095 |
132 | cellular response to vitamin (GO:0071295) | 2.80524214 |
133 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.80003032 |
134 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.79259905 |
135 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.79009694 |
136 | triglyceride biosynthetic process (GO:0019432) | 2.78759783 |
137 | triglyceride metabolic process (GO:0006641) | 2.78714773 |
138 | regulation of cholesterol storage (GO:0010885) | 2.75860069 |
139 | midgut development (GO:0007494) | 2.75244230 |
140 | collagen fibril organization (GO:0030199) | 2.73741908 |
141 | ethanol metabolic process (GO:0006067) | 2.72919565 |
142 | negative regulation of blood coagulation (GO:0030195) | 2.72152174 |
143 | negative regulation of hemostasis (GO:1900047) | 2.72152174 |
144 | negative regulation of coagulation (GO:0050819) | 2.70973511 |
145 | acylglycerol biosynthetic process (GO:0046463) | 2.70497340 |
146 | neutral lipid biosynthetic process (GO:0046460) | 2.70497340 |
147 | glycerolipid catabolic process (GO:0046503) | 2.69587696 |
148 | positive regulation of blood coagulation (GO:0030194) | 2.67257884 |
149 | positive regulation of hemostasis (GO:1900048) | 2.67257884 |
150 | thioester metabolic process (GO:0035383) | 2.66282653 |
151 | acyl-CoA metabolic process (GO:0006637) | 2.66282653 |
152 | negative regulation of wound healing (GO:0061045) | 2.65893900 |
153 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.65576298 |
154 | COPII vesicle coating (GO:0048208) | 2.64401569 |
155 | thioester biosynthetic process (GO:0035384) | 2.63163090 |
156 | acyl-CoA biosynthetic process (GO:0071616) | 2.63163090 |
157 | positive regulation of coagulation (GO:0050820) | 2.59880675 |
158 | lipid storage (GO:0019915) | 2.58901073 |
159 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.58434453 |
160 | negative regulation of lipid transport (GO:0032369) | 2.57423901 |
161 | chondrocyte proliferation (GO:0035988) | 2.56894844 |
162 | acylglycerol metabolic process (GO:0006639) | 2.56039617 |
163 | regulation of apoptotic cell clearance (GO:2000425) | 2.55641311 |
164 | neutral lipid metabolic process (GO:0006638) | 2.51727168 |
165 | negative regulation of protein activation cascade (GO:2000258) | 2.50935916 |
166 | adhesion of symbiont to host cell (GO:0044650) | 2.50895887 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.75021895 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.81168302 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.77039902 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09671479 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.78556949 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.57425424 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.36750712 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83336740 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.45717834 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.11320662 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.73936846 |
12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.30213189 |
13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.26766579 |
14 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.26597938 |
15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07651196 |
16 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.07252668 |
17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8618654 |
18 | CJUN_26792858_Chip-Seq_BT549_Human | 1.88549896 |
19 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.85481493 |
20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.79643592 |
21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.75435154 |
22 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.69380231 |
23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68629578 |
24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.67254764 |
25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65138713 |
26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64568665 |
27 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.62640606 |
28 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.62640606 |
29 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.58745116 |
30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48719212 |
31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46344612 |
32 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44365326 |
33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41153953 |
34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36977236 |
35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35400478 |
36 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34995466 |
37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33709009 |
38 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.33003446 |
39 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.30744911 |
40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27625099 |
41 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.26888427 |
42 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.22834874 |
43 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22237174 |
44 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20768360 |
45 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.20076140 |
46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19910220 |
47 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18770772 |
48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18090512 |
49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16944406 |
50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14633554 |
51 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12003422 |
52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11584245 |
53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11179666 |
54 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.11023734 |
55 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10166651 |
56 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.10119033 |
57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08138386 |
58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07256297 |
59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07193320 |
60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01807915 |
61 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00631950 |
62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00191982 |
63 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99208933 |
64 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99161976 |
65 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.98781873 |
66 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.98411672 |
67 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98276469 |
68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97893827 |
69 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.97185382 |
70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95897346 |
71 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94553697 |
72 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93717001 |
73 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.93152912 |
74 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91354037 |
75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90833920 |
76 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.90624341 |
77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90487291 |
78 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89814930 |
79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89467900 |
80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87685270 |
81 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87323159 |
82 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87077964 |
83 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86360281 |
84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85460210 |
85 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84937551 |
86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84518258 |
87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84059099 |
88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83705381 |
89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83116156 |
90 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.82627541 |
91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.82231085 |
92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81361191 |
93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80243035 |
94 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.80067237 |
95 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79142726 |
96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79134640 |
97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78615478 |
98 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.78230933 |
99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76954291 |
100 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76513827 |
101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74954111 |
102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.70496629 |
103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70334760 |
104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70001116 |
105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70001116 |
106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68140166 |
107 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67437914 |
108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.67008025 |
109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66886652 |
110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66660066 |
111 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.66431268 |
112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.64852872 |
113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63342175 |
114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63256236 |
115 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63119317 |
116 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62618386 |
117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62070253 |
118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.60630925 |
119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.60630925 |
120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.60060395 |
121 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.59240473 |
122 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.58402423 |
123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58363709 |
124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58275906 |
125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58029503 |
126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56755736 |
127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56313006 |
128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.55354104 |
129 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.54986201 |
130 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.54810380 |
131 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.53620208 |
132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53128043 |
133 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51958169 |
134 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50741624 |
135 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49947074 |
136 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.49548793 |
137 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.48610339 |
138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47542551 |
139 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.45838637 |
140 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.44100022 |
141 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.43744889 |
142 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.43533560 |
143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.42714136 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.58046416 |
2 | MP0005360_urolithiasis | 7.56450367 |
3 | MP0005365_abnormal_bile_salt | 5.52575066 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.47434757 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.41977095 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.92886668 |
7 | MP0003252_abnormal_bile_duct | 3.57462804 |
8 | MP0010329_abnormal_lipoprotein_level | 3.49302865 |
9 | MP0005332_abnormal_amino_acid | 2.99429095 |
10 | MP0009840_abnormal_foam_cell | 2.93869562 |
11 | MP0003950_abnormal_plasma_membrane | 2.78194634 |
12 | MP0005083_abnormal_biliary_tract | 2.62176586 |
13 | MP0003195_calcinosis | 2.61419881 |
14 | MP0003566_abnormal_cell_adhesion | 2.51615692 |
15 | MP0001666_abnormal_nutrient_absorption | 2.49718142 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.49660400 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.45887209 |
18 | MP0003279_aneurysm | 2.30573547 |
19 | MP0005257_abnormal_intraocular_pressure | 2.25951144 |
20 | MP0002118_abnormal_lipid_homeostasis | 2.14772917 |
21 | MP0000609_abnormal_liver_physiology | 2.09894953 |
22 | MP0005670_abnormal_white_adipose | 2.03912155 |
23 | MP0003705_abnormal_hypodermis_morpholog | 2.02081064 |
24 | MP0002138_abnormal_hepatobiliary_system | 2.00194770 |
25 | MP0010352_gastrointestinal_tract_polyps | 1.97767279 |
26 | MP0003941_abnormal_skin_development | 1.87577292 |
27 | MP0001958_emphysema | 1.86425257 |
28 | MP0006054_spinal_hemorrhage | 1.83560915 |
29 | MP0005503_abnormal_tendon_morphology | 1.83467066 |
30 | MP0000751_myopathy | 1.82594342 |
31 | MP0005319_abnormal_enzyme/_coenzyme | 1.76929329 |
32 | MP0009643_abnormal_urine_homeostasis | 1.70021131 |
33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57747374 |
34 | MP0001764_abnormal_homeostasis | 1.51042835 |
35 | MP0003091_abnormal_cell_migration | 1.50653351 |
36 | MP0005623_abnormal_meninges_morphology | 1.48864138 |
37 | MP0003186_abnormal_redox_activity | 1.46459775 |
38 | MP0002877_abnormal_melanocyte_morpholog | 1.45535436 |
39 | MP0005666_abnormal_adipose_tissue | 1.42455496 |
40 | MP0000003_abnormal_adipose_tissue | 1.41282362 |
41 | MP0003868_abnormal_feces_composition | 1.34846321 |
42 | MP0003011_delayed_dark_adaptation | 1.32001401 |
43 | MP0006138_congestive_heart_failure | 1.31816531 |
44 | MP0004130_abnormal_muscle_cell | 1.31694902 |
45 | MP0000013_abnormal_adipose_tissue | 1.27440787 |
46 | MP0000767_abnormal_smooth_muscle | 1.25621522 |
47 | MP0003828_pulmonary_edema | 1.22295616 |
48 | MP0009780_abnormal_chondrocyte_physiolo | 1.20858970 |
49 | MP0005595_abnormal_vascular_smooth | 1.20439386 |
50 | MP0001542_abnormal_bone_strength | 1.18979577 |
51 | MP0002896_abnormal_bone_mineralization | 1.17744081 |
52 | MP0000598_abnormal_liver_morphology | 1.15924799 |
53 | MP0005451_abnormal_body_composition | 1.15481610 |
54 | MP0000343_altered_response_to | 1.14487567 |
55 | MP0002971_abnormal_brown_adipose | 1.12265989 |
56 | MP0001756_abnormal_urination | 1.07855940 |
57 | MP0002254_reproductive_system_inflammat | 1.06376289 |
58 | MP0005164_abnormal_response_to | 1.04847290 |
59 | MP0000749_muscle_degeneration | 1.03061493 |
60 | MP0008438_abnormal_cutaneous_collagen | 1.02670951 |
61 | * MP0005636_abnormal_mineral_homeostasis | 0.99965528 |
62 | MP0004233_abnormal_muscle_weight | 0.98171459 |
63 | MP0004185_abnormal_adipocyte_glucose | 0.97502278 |
64 | MP0001243_abnormal_dermal_layer | 0.97325538 |
65 | MP0001661_extended_life_span | 0.96276523 |
66 | MP0000604_amyloidosis | 0.92375377 |
67 | MP0004858_abnormal_nervous_system | 0.92305137 |
68 | MP0009763_increased_sensitivity_to | 0.91649914 |
69 | MP0005165_increased_susceptibility_to | 0.91638648 |
70 | MP0005508_abnormal_skeleton_morphology | 0.91605522 |
71 | MP0009697_abnormal_copulation | 0.90561622 |
72 | MP0005334_abnormal_fat_pad | 0.90134419 |
73 | MP0004043_abnormal_pH_regulation | 0.89371217 |
74 | MP0001299_abnormal_eye_distance/ | 0.88180518 |
75 | MP0004087_abnormal_muscle_fiber | 0.86845338 |
76 | MP0005647_abnormal_sex_gland | 0.85735857 |
77 | MP0001849_ear_inflammation | 0.85357119 |
78 | MP0000759_abnormal_skeletal_muscle | 0.84766045 |
79 | MP0002136_abnormal_kidney_physiology | 0.84469624 |
80 | MP0005084_abnormal_gallbladder_morpholo | 0.83071939 |
81 | MP0003656_abnormal_erythrocyte_physiolo | 0.83002458 |
82 | MP0002078_abnormal_glucose_homeostasis | 0.82474999 |
83 | MP0006036_abnormal_mitochondrial_physio | 0.81914836 |
84 | MP0002876_abnormal_thyroid_physiology | 0.81699525 |
85 | MP0004084_abnormal_cardiac_muscle | 0.81668153 |
86 | MP0009642_abnormal_blood_homeostasis | 0.80861394 |
87 | MP0005375_adipose_tissue_phenotype | 0.80838305 |
88 | MP0010368_abnormal_lymphatic_system | 0.79936317 |
89 | MP0005408_hypopigmentation | 0.78990713 |
90 | MP0009764_decreased_sensitivity_to | 0.78183838 |
91 | MP0009115_abnormal_fat_cell | 0.76343670 |
92 | MP0010030_abnormal_orbit_morphology | 0.76126638 |
93 | MP0005330_cardiomyopathy | 0.75153085 |
94 | MP0000858_altered_metastatic_potential | 0.74723703 |
95 | MP0005376_homeostasis/metabolism_phenot | 0.74640545 |
96 | MP0003690_abnormal_glial_cell | 0.73921395 |
97 | MP0005535_abnormal_body_temperature | 0.73217455 |
98 | MP0009053_abnormal_anal_canal | 0.72188241 |
99 | MP0008469_abnormal_protein_level | 0.71381227 |
100 | MP0003448_altered_tumor_morphology | 0.71165141 |
101 | MP0002108_abnormal_muscle_morphology | 0.70890474 |
102 | MP0005058_abnormal_lysosome_morphology | 0.70316242 |
103 | MP0005220_abnormal_exocrine_pancreas | 0.70139464 |
104 | MP0002128_abnormal_blood_circulation | 0.69833109 |
105 | MP0000733_abnormal_muscle_development | 0.69724701 |
106 | MP0002972_abnormal_cardiac_muscle | 0.69302078 |
107 | MP0000747_muscle_weakness | 0.68954754 |
108 | MP0004036_abnormal_muscle_relaxation | 0.67786435 |
109 | MP0001879_abnormal_lymphatic_vessel | 0.66555438 |
110 | MP0001614_abnormal_blood_vessel | 0.66141648 |
111 | MP0008775_abnormal_heart_ventricle | 0.65786079 |
112 | MP0005266_abnormal_metabolism | 0.64764470 |
113 | MP0005197_abnormal_uvea_morphology | 0.64693079 |
114 | MP0005448_abnormal_energy_balance | 0.64542638 |
115 | MP0005385_cardiovascular_system_phenoty | 0.63413482 |
116 | MP0001544_abnormal_cardiovascular_syste | 0.63413482 |
117 | MP0009765_abnormal_xenobiotic_induced | 0.62972340 |
118 | MP0003300_gastrointestinal_ulcer | 0.59520472 |
119 | MP0002970_abnormal_white_adipose | 0.59285576 |
120 | MP0002168_other_aberrant_phenotype | 0.59131666 |
121 | MP0001881_abnormal_mammary_gland | 0.57980874 |
122 | MP0005395_other_phenotype | 0.56182283 |
123 | MP0010234_abnormal_vibrissa_follicle | 0.55945009 |
124 | MP0009384_cardiac_valve_regurgitation | 0.53158878 |
125 | MP0002837_dystrophic_cardiac_calcinosis | 0.52485027 |
126 | MP0003329_amyloid_beta_deposits | 0.52482304 |
127 | MP0002796_impaired_skin_barrier | 0.51615149 |
128 | MP0004272_abnormal_basement_membrane | 0.51577588 |
129 | MP0003959_abnormal_lean_body | 0.50942478 |
130 | MP0009672_abnormal_birth_weight | 0.50118404 |
131 | MP0004782_abnormal_surfactant_physiolog | 0.49957142 |
132 | MP0005275_abnormal_skin_tensile | 0.47884153 |
133 | MP0004264_abnormal_extraembryonic_tissu | 0.47553654 |
134 | MP0001765_abnormal_ion_homeostasis | 0.46844819 |
135 | MP0008961_abnormal_basal_metabolism | 0.43706333 |
136 | MP0003953_abnormal_hormone_level | 0.43134201 |
137 | MP0002928_abnormal_bile_duct | 0.42318992 |
138 | MP0003638_abnormal_response/metabolism_ | 0.41918523 |
139 | MP0002135_abnormal_kidney_morphology | 0.41341003 |
140 | MP0005167_abnormal_blood-brain_barrier | 0.40848211 |
141 | MP0005248_abnormal_Harderian_gland | 0.40680563 |
142 | MP0000230_abnormal_systemic_arterial | 0.40087018 |
143 | MP0002060_abnormal_skin_morphology | 0.39366548 |
144 | MP0003724_increased_susceptibility_to | 0.38942387 |
145 | MP0001915_intracranial_hemorrhage | 0.37952471 |
146 | MP0006035_abnormal_mitochondrial_morpho | 0.36695997 |
147 | MP0000249_abnormal_blood_vessel | 0.36499031 |
148 | MP0002295_abnormal_pulmonary_circulatio | 0.36059297 |
149 | MP0005023_abnormal_wound_healing | 0.35503100 |
150 | MP0008873_increased_physiological_sensi | 0.35004588 |
151 | MP0000639_abnormal_adrenal_gland | 0.34197581 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 6.28746582 |
2 | Deep venous thrombosis (HP:0002625) | 6.18782891 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.08158852 |
4 | Premature rupture of membranes (HP:0001788) | 5.85969114 |
5 | Xanthomatosis (HP:0000991) | 5.83854401 |
6 | Protrusio acetabuli (HP:0003179) | 5.78026781 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.61651083 |
8 | Hypobetalipoproteinemia (HP:0003563) | 5.32928709 |
9 | Hyperglycinuria (HP:0003108) | 4.96307323 |
10 | Prolonged partial thromboplastin time (HP:0003645) | 4.93572927 |
11 | Complement deficiency (HP:0004431) | 4.74182283 |
12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.72020246 |
13 | Hyperammonemia (HP:0001987) | 4.70019286 |
14 | Abnormality of glycine metabolism (HP:0010895) | 4.66035679 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.66035679 |
16 | Hyperlipoproteinemia (HP:0010980) | 4.62805916 |
17 | Ketosis (HP:0001946) | 4.46983760 |
18 | Hyperglycinemia (HP:0002154) | 4.43294905 |
19 | Epidermoid cyst (HP:0200040) | 4.29070387 |
20 | Hypolipoproteinemia (HP:0010981) | 4.27596332 |
21 | Hypoglycemic coma (HP:0001325) | 4.24583224 |
22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.98548927 |
23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.97230405 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.96105122 |
25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.95446773 |
26 | Hypoalphalipoproteinemia (HP:0003233) | 3.91030136 |
27 | Ankle contracture (HP:0006466) | 3.81236784 |
28 | Vertebral compression fractures (HP:0002953) | 3.80724342 |
29 | Joint hemorrhage (HP:0005261) | 3.73927582 |
30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.69049249 |
31 | Vascular tortuosity (HP:0004948) | 3.64609080 |
32 | Ketoacidosis (HP:0001993) | 3.64352463 |
33 | Fat malabsorption (HP:0002630) | 3.61610233 |
34 | Aortic dissection (HP:0002647) | 3.59969327 |
35 | Aortic aneurysm (HP:0004942) | 3.52700459 |
36 | Abnormality of methionine metabolism (HP:0010901) | 3.43829076 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42747222 |
38 | Abnormality of complement system (HP:0005339) | 3.40928315 |
39 | Hypercholesterolemia (HP:0003124) | 3.39568858 |
40 | Arterial tortuosity (HP:0005116) | 3.38805211 |
41 | Abnormality of purine metabolism (HP:0004352) | 3.34684515 |
42 | Spinal rigidity (HP:0003306) | 3.30991899 |
43 | Gout (HP:0001997) | 3.29725048 |
44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.27572606 |
45 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.13348789 |
46 | Abnormality of the intrinsic pathway (HP:0010989) | 3.10063260 |
47 | Delayed CNS myelination (HP:0002188) | 3.08944936 |
48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.02299277 |
49 | Dicarboxylic aciduria (HP:0003215) | 3.02299277 |
50 | Cervical subluxation (HP:0003308) | 2.97652486 |
51 | Abnormality of serum amino acid levels (HP:0003112) | 2.96874291 |
52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.92220621 |
53 | Osteolytic defects of the hand bones (HP:0009699) | 2.92220621 |
54 | Hepatocellular carcinoma (HP:0001402) | 2.90938823 |
55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90197535 |
56 | Soft skin (HP:0000977) | 2.88287050 |
57 | Myocardial infarction (HP:0001658) | 2.86021293 |
58 | Wormian bones (HP:0002645) | 2.85135446 |
59 | Hyperbilirubinemia (HP:0002904) | 2.81841182 |
60 | Metabolic acidosis (HP:0001942) | 2.79820917 |
61 | Abnormality of proline metabolism (HP:0010907) | 2.79172605 |
62 | Hydroxyprolinuria (HP:0003080) | 2.79172605 |
63 | Type 1 muscle fiber predominance (HP:0003803) | 2.76404192 |
64 | Spastic diplegia (HP:0001264) | 2.76387544 |
65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73665171 |
66 | Skin nodule (HP:0200036) | 2.72291378 |
67 | Generalized aminoaciduria (HP:0002909) | 2.71966671 |
68 | Follicular hyperkeratosis (HP:0007502) | 2.64379371 |
69 | Lethargy (HP:0001254) | 2.63945270 |
70 | Steatorrhea (HP:0002570) | 2.62921252 |
71 | Proximal tubulopathy (HP:0000114) | 2.60369924 |
72 | Increased purine levels (HP:0004368) | 2.53760993 |
73 | Hyperuricemia (HP:0002149) | 2.53760993 |
74 | Vascular calcification (HP:0004934) | 2.53104944 |
75 | Atrophic scars (HP:0001075) | 2.52670167 |
76 | Hypoglycemic seizures (HP:0002173) | 2.51263316 |
77 | Blue sclerae (HP:0000592) | 2.49616189 |
78 | Systemic lupus erythematosus (HP:0002725) | 2.48925584 |
79 | Bladder diverticulum (HP:0000015) | 2.45855178 |
80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.44002199 |
81 | Short nail (HP:0001799) | 2.41389173 |
82 | Increased connective tissue (HP:0009025) | 2.40795470 |
83 | Abnormal cartilage morphology (HP:0002763) | 2.40632913 |
84 | Esophageal varix (HP:0002040) | 2.40378234 |
85 | Fragile skin (HP:0001030) | 2.40361055 |
86 | Malnutrition (HP:0004395) | 2.39176346 |
87 | Cardiovascular calcification (HP:0011915) | 2.35368962 |
88 | Shallow orbits (HP:0000586) | 2.35288182 |
89 | Abnormal delivery (HP:0001787) | 2.34343812 |
90 | Broad metatarsal (HP:0001783) | 2.32573874 |
91 | Abnormality of dentin (HP:0010299) | 2.30507599 |
92 | Irritability (HP:0000737) | 2.29091518 |
93 | Vomiting (HP:0002013) | 2.28452779 |
94 | Dilatation of the ascending aorta (HP:0005111) | 2.26807617 |
95 | Alkalosis (HP:0001948) | 2.26800464 |
96 | Pancreatitis (HP:0001733) | 2.23652308 |
97 | Enlarged kidneys (HP:0000105) | 2.22798839 |
98 | Mitral valve prolapse (HP:0001634) | 2.22100294 |
99 | Abnormality of the acetabulum (HP:0003170) | 2.21866013 |
100 | Nausea (HP:0002018) | 2.20727084 |
101 | Acanthosis nigricans (HP:0000956) | 2.19254192 |
102 | Sensorimotor neuropathy (HP:0007141) | 2.19107779 |
103 | Neonatal onset (HP:0003623) | 2.18965050 |
104 | Cerebral aneurysm (HP:0004944) | 2.18854230 |
105 | Cerebral edema (HP:0002181) | 2.18364905 |
106 | Late onset (HP:0003584) | 2.14605296 |
107 | Hemorrhage of the eye (HP:0011885) | 2.13128143 |
108 | Hypertriglyceridemia (HP:0002155) | 2.11806166 |
109 | Abnormality of the Achilles tendon (HP:0005109) | 2.09032393 |
110 | Abnormal gallbladder morphology (HP:0012437) | 2.09015966 |
111 | Acanthocytosis (HP:0001927) | 2.08877347 |
112 | Cholelithiasis (HP:0001081) | 2.07928609 |
113 | Spontaneous abortion (HP:0005268) | 2.07780764 |
114 | Biconcave vertebral bodies (HP:0004586) | 2.06966641 |
115 | Mitral stenosis (HP:0001718) | 2.06554213 |
116 | Abnormality of carpal bone ossification (HP:0006257) | 2.06396492 |
117 | Slender build (HP:0001533) | 2.06144578 |
118 | Abnormality of urine glucose concentration (HP:0011016) | 2.05743907 |
119 | Glycosuria (HP:0003076) | 2.05743907 |
120 | Aneurysm (HP:0002617) | 2.05181932 |
121 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.04082885 |
122 | Hypochromic microcytic anemia (HP:0004840) | 2.01485323 |
123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00928543 |
124 | Glomerulonephritis (HP:0000099) | 2.00312408 |
125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99811387 |
126 | Abnormal gallbladder physiology (HP:0012438) | 1.96687828 |
127 | Cholecystitis (HP:0001082) | 1.96687828 |
128 | Rickets (HP:0002748) | 1.96295940 |
129 | Nephritis (HP:0000123) | 1.95542640 |
130 | Achilles tendon contracture (HP:0001771) | 1.95099149 |
131 | Brushfield spots (HP:0001088) | 1.94565424 |
132 | Tetraparesis (HP:0002273) | 1.94394831 |
133 | Ectopia lentis (HP:0001083) | 1.91071216 |
134 | Peritonitis (HP:0002586) | 1.90079863 |
135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89400004 |
136 | Mucopolysacchariduria (HP:0008155) | 1.89400004 |
137 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88969413 |
138 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88969413 |
139 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88969413 |
140 | Insulin resistance (HP:0000855) | 1.88220035 |
141 | Ulnar bowing (HP:0003031) | 1.87810941 |
142 | Joint laxity (HP:0001388) | 1.87648235 |
143 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.86880684 |
144 | Neonatal short-limb short stature (HP:0008921) | 1.86009695 |
145 | Nephrolithiasis (HP:0000787) | 1.85488437 |
146 | Back pain (HP:0003418) | 1.84148847 |
147 | Amyloidosis (HP:0011034) | 1.83773544 |
148 | Increased mean platelet volume (HP:0011877) | 1.82751165 |
149 | Elbow flexion contracture (HP:0002987) | 1.82371281 |
150 | Polycythemia (HP:0001901) | 1.81150905 |
151 | Abnormality of the gallbladder (HP:0005264) | 1.80425790 |
152 | Hyperextensible skin (HP:0000974) | 1.80294673 |
153 | Ovoid vertebral bodies (HP:0003300) | 1.80142900 |
154 | Abnormal ossification of hand bones (HP:0005921) | 1.79638846 |
155 | Axonal loss (HP:0003447) | 1.79205032 |
156 | Asymmetric septal hypertrophy (HP:0001670) | 1.78539744 |
157 | Opisthotonus (HP:0002179) | 1.77441321 |
158 | Spondylolisthesis (HP:0003302) | 1.76089078 |
159 | Renal cortical cysts (HP:0000803) | 1.75498323 |
160 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75337241 |
161 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75337241 |
162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75337241 |
163 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75037631 |
164 | Hyperglycemia (HP:0003074) | 1.74599541 |
165 | Myoglobinuria (HP:0002913) | 1.73676847 |
166 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.71588985 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.39941513 |
2 | SIK1 | 4.43312070 |
3 | MYLK | 3.78902862 |
4 | ERN1 | 3.74680771 |
5 | TRIB3 | 3.62587348 |
6 | FGFR4 | 3.50418295 |
7 | PKN2 | 2.58399808 |
8 | CAMK1D | 2.54561318 |
9 | TIE1 | 2.31795832 |
10 | TESK1 | 2.28931755 |
11 | LATS1 | 2.18981563 |
12 | MST1R | 2.18257010 |
13 | INSRR | 2.12839680 |
14 | LIMK1 | 1.93159515 |
15 | ERBB4 | 1.92584557 |
16 | IRAK3 | 1.83398127 |
17 | NTRK1 | 1.75685785 |
18 | PTK6 | 1.74944734 |
19 | WNK4 | 1.56842572 |
20 | CAMK1G | 1.56244190 |
21 | MAPK11 | 1.48617539 |
22 | FRK | 1.47016580 |
23 | NEK9 | 1.45937066 |
24 | SCYL2 | 1.44233619 |
25 | TRPM7 | 1.42786216 |
26 | MET | 1.42651518 |
27 | MOS | 1.40369035 |
28 | RIPK1 | 1.39584660 |
29 | EPHB1 | 1.38530816 |
30 | FLT3 | 1.34721496 |
31 | PDK4 | 1.34318568 |
32 | PDK3 | 1.34318568 |
33 | FGFR2 | 1.31524866 |
34 | WNK3 | 1.31421544 |
35 | STK38L | 1.31005314 |
36 | TAOK3 | 1.23662174 |
37 | PRKAA2 | 1.21336351 |
38 | MAP3K10 | 1.11883476 |
39 | MAP3K3 | 1.07564893 |
40 | PDGFRA | 1.07004735 |
41 | MAP3K6 | 1.05530711 |
42 | ABL2 | 1.05392015 |
43 | AKT3 | 1.03341366 |
44 | BMX | 1.03167707 |
45 | STK38 | 1.02663073 |
46 | KDR | 1.01609327 |
47 | TYK2 | 0.99845983 |
48 | PRKG2 | 0.99133212 |
49 | CDK6 | 0.98944487 |
50 | OXSR1 | 0.96789933 |
51 | ERBB2 | 0.92762132 |
52 | JAK2 | 0.91897905 |
53 | MAP2K3 | 0.90845278 |
54 | LMTK2 | 0.90033064 |
55 | CDC42BPA | 0.89365879 |
56 | PIK3CG | 0.89226566 |
57 | GSK3A | 0.87212159 |
58 | TGFBR2 | 0.85330328 |
59 | PIM2 | 0.81461326 |
60 | PTK2 | 0.81390354 |
61 | MAP3K7 | 0.81113223 |
62 | ARAF | 0.80834705 |
63 | NEK1 | 0.78227128 |
64 | PRKAA1 | 0.78040518 |
65 | MTOR | 0.77332982 |
66 | PDK2 | 0.77197583 |
67 | ICK | 0.76766428 |
68 | TBK1 | 0.74070168 |
69 | EPHB2 | 0.71778351 |
70 | JAK1 | 0.71518677 |
71 | MAP2K4 | 0.71176462 |
72 | LRRK2 | 0.71150280 |
73 | GRK6 | 0.68373077 |
74 | MAP3K12 | 0.68363973 |
75 | ROCK2 | 0.67177045 |
76 | DAPK3 | 0.66137292 |
77 | DYRK1B | 0.65795812 |
78 | MAP2K1 | 0.65430857 |
79 | FGFR3 | 0.64883422 |
80 | LATS2 | 0.64846737 |
81 | ROCK1 | 0.63271692 |
82 | EPHA3 | 0.63132261 |
83 | PRKCZ | 0.62098201 |
84 | PRKACG | 0.58190283 |
85 | SGK3 | 0.56331429 |
86 | CDK4 | 0.56183387 |
87 | PRKD2 | 0.55904889 |
88 | STK3 | 0.55874568 |
89 | TTN | 0.55524537 |
90 | MAP2K2 | 0.55100581 |
91 | DMPK | 0.54947764 |
92 | PDPK1 | 0.51801849 |
93 | FGFR1 | 0.51340941 |
94 | TTK | 0.51260282 |
95 | DAPK2 | 0.51163115 |
96 | EPHA2 | 0.49563250 |
97 | CSK | 0.48378734 |
98 | PASK | 0.48363465 |
99 | MELK | 0.47984117 |
100 | FER | 0.45862718 |
101 | RET | 0.45455849 |
102 | KSR2 | 0.45219190 |
103 | SMG1 | 0.44445089 |
104 | BRSK2 | 0.44120457 |
105 | AKT2 | 0.44109035 |
106 | DDR2 | 0.43649002 |
107 | IGF1R | 0.43636830 |
108 | PAK4 | 0.43031033 |
109 | GRK7 | 0.41141019 |
110 | CLK1 | 0.40335857 |
111 | PAK2 | 0.40063647 |
112 | ILK | 0.39513257 |
113 | MAP3K5 | 0.39288528 |
114 | CAMK2G | 0.39088685 |
115 | RPS6KA2 | 0.39018476 |
116 | CAMK2D | 0.38868729 |
117 | SGK223 | 0.38840764 |
118 | SGK494 | 0.38840764 |
119 | MAPK4 | 0.38814341 |
120 | PAK1 | 0.38622071 |
121 | STK39 | 0.38382021 |
122 | CSF1R | 0.38007982 |
123 | NME2 | 0.37492439 |
124 | PAK3 | 0.37431504 |
125 | MAPKAPK3 | 0.37301330 |
126 | ADRBK1 | 0.37222173 |
127 | MAP3K11 | 0.35849252 |
128 | GRK5 | 0.34770421 |
129 | CSNK1G1 | 0.34433000 |
130 | STK4 | 0.34243528 |
131 | PIK3CA | 0.33655636 |
132 | CDK9 | 0.31760195 |
133 | TSSK6 | 0.30297107 |
134 | MAP3K8 | 0.29967543 |
135 | TAOK2 | 0.29687582 |
136 | PBK | 0.29027414 |
137 | TGFBR1 | 0.28777666 |
138 | EGFR | 0.28598386 |
139 | SRC | 0.27838249 |
140 | EEF2K | 0.27448643 |
141 | GRK1 | 0.26599774 |
142 | PDGFRB | 0.25871453 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.79538793 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45171111 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20383383 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84917260 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.84004288 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81784982 |
7 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.72479937 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.68328798 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63075506 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62412561 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.55270442 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41373949 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40663411 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26141538 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.24403076 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.23983138 |
17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23565848 |
18 | Peroxisome_Homo sapiens_hsa04146 | 2.14848776 |
19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89301689 |
20 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.88280697 |
21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87385182 |
22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83483449 |
23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72691007 |
24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67021836 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66467228 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66243792 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62927321 |
28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59923196 |
29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.58517349 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55969466 |
31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52799404 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50453122 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.50189719 |
34 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.44664135 |
35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44501099 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44427126 |
37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42073978 |
38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40810872 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39838352 |
40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35226984 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30843023 |
42 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25184812 |
43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24991337 |
44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23043860 |
45 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19757647 |
46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19189319 |
47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18075532 |
48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17427973 |
49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16943658 |
50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13936266 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10747396 |
52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09716653 |
53 | Focal adhesion_Homo sapiens_hsa04510 | 1.08989099 |
54 | ABC transporters_Homo sapiens_hsa02010 | 1.07283315 |
55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05114300 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03260686 |
57 | Lysine degradation_Homo sapiens_hsa00310 | 0.98947102 |
58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97140153 |
59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89455802 |
60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87401732 |
61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86789813 |
62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86361272 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85474239 |
64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82019631 |
65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80413287 |
66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76573213 |
67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75468564 |
68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74891802 |
69 | Adherens junction_Homo sapiens_hsa04520 | 0.72430404 |
70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72161318 |
71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68305648 |
72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61473656 |
73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61187850 |
74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59973057 |
75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50943175 |
76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50397342 |
77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44957881 |
78 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44513692 |
79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41419907 |
80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41228518 |
81 | Insulin resistance_Homo sapiens_hsa04931 | 0.38769741 |
82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37954648 |
83 | Pertussis_Homo sapiens_hsa05133 | 0.35914093 |
84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35642356 |
85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35032178 |
86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34177021 |
87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34017408 |
88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32751833 |
89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31479604 |
90 | Tight junction_Homo sapiens_hsa04530 | 0.29185489 |
91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29007047 |
92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25497634 |
93 | Prion diseases_Homo sapiens_hsa05020 | 0.21541893 |
94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15958882 |
95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14463641 |
96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12907777 |
97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10724553 |
98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08795868 |
99 | Mineral absorption_Homo sapiens_hsa04978 | 0.03558032 |
100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02052084 |
101 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1462642 |
102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1402945 |
103 | Amoebiasis_Homo sapiens_hsa05146 | -0.1387842 |
104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1257226 |
105 | Hepatitis C_Homo sapiens_hsa05160 | -0.1223199 |
106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1144365 |
107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1040952 |
108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0907973 |
109 | Bladder cancer_Homo sapiens_hsa05219 | -0.0871357 |
110 | Lysosome_Homo sapiens_hsa04142 | -0.0848598 |
111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0790670 |
112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0748882 |
113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0443342 |
114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0372584 |
115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0304557 |
116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0257120 |
117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0145336 |